SOPHiA GENETICS SA
corporate_fare Company Profile
SOPHiA GENETICS SA (NASDAQ:SOPH) is a publicly traded company in the Technology sector. Wiseek monitors SOPH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- SOPHiA GENETICS Closes $57.5M Public Offering with Full Underwriter Option Exercise
- Shareholders Formalize CEO Transition, Elect Executive Chairman, and Approve Governance Enhancements
- SOPHiA GENETICS Prices $50M Public Offering at $4.75/Share
- Sophia Genetics Shares Jump 8.7% Following $50M Stock Offering Pricing
- SOPHiA GENETICS Prices $50M Public Offering at $4.75 Per Share
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for SOPH, detected from its recent SEC filings · based on capital-structure filings through 2026-06-22.
Public Offering Priced · Substantial Capital Raised
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
SOPH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.